Rexahn is one stock to watch. Few drugs in a pipeline plus pending partnership deal, this stock is ready to move up. Before this happens few things need to be cleared out. Weak holders, panic sellers and reverse stock split in the summer. Analyst who cover this stock target 3pps as average target. But longturn if any of its drugs gets on FDA approval list this could easily blast 3 digits.
On technical side, price has been rejected on 1.08 several times which is now well established support. 1,11 is 50% fib level good for bounce.Major resistance levels are 1.30, 1.50 and 1.80 .Preaty cheap stock regarding its potential.
rexahn.com/pdf/newwww/2014_AACR_poster_RX-3117.pdf